JC

Jaseela Chalooth

Active Director Designated Partner DIN 10186330
DIN 10186330 First appointment May 2023 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Jaseela Chalooth

Data last updated:

Jaseela Chalooth is a Designated Partner at Inomo Drugs Llp (since 2023). The company operates in Business Services.

DIN 10186330
Primary Designation Designated Partner
Industry Business Services
First Appointment 31 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Inomo Drugs Llp ACB-4432
Designated Partner31 May 20232023Active

Board colleagues of Jaseela Chalooth

NameDINCompanyDesignation
Mohammed Irshad Cheenikkal10186329Inomo Drugs LlpDesignated Partner
Mohammed Shamsudeen10186331Inomo Drugs LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Inomo Drugs Llp
Premium access

Shareholding and investment profile for Jaseela Chalooth

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jaseela Chalooth

Jaseela Chalooth currently holds 1 directorship: Inomo Drugs Llp (Designated Partner, since 31 May 2023).

Jaseela Chalooth was first appointed on 31 May 2023 as Designated Partner at Inomo Drugs Llp.

The current boards of Jaseela Chalooth's companies include Mohammed Irshad Cheenikkal (Inomo Drugs Llp), Mohammed Shamsudeen (Inomo Drugs Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available